COSMED Announces Acquisition of Innovision Technology to Expand Product Portfolio and Presence in the Nordic Markets.

COSMED headquartered in Rome, Italy, leading manufacturer of Metabolic and Body composition technologies, has acquired assets of Innovision ApS, a Danish Company with significant know-how and expertise in the design of products for Hemodynamic (Cardiac Output), Ventilation Heterogeneity (Lung Clearance Index) and Metabolic measurements (VO2Max).

COSMED is glad to announce the U.S. Food and Drug Administration (FDA) clearance of Q-NRG+ and Q-NRG, a metabolic monitoring device utilizing Indirect Calorimetry (IC) technology intended for the measurement of Resting Energy Expenditure (REE) in patients who are mechanically ventilated or spontaneously breathing.

Visit COSMED booth R.C50 during 2019 Arab Health healthcare exhibition! New distributors are welcome!

Visit COSMED booth Halle 11 #A25 during 2018 MEDICA Tradefair! New distributors are welcome!

The 2018 ESICM (European Society of Intensive Care Medicine) Congress will host a Satellite Symposium sponsored by COSMED dedicated to indirect calorimetry in critically ill patients, including an introduction of the main breakthroughs of the new Q-NRG metabolic monitor.